ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,694Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 2888

$2.93M Total Retail Price of All Prescriptions

Rank: 7 out of 2888

1,258 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

31% of this provider’s 1,258 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 23,649 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$92 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 1,554 967 S3 1 4
LEVOTHYROXINE SODIUM 1,139 853 2 1
METFORMIN HCL 1,057 754 3 8
SIMVASTATIN 1,007 830 4 2
OMEPRAZOLE 974 770 5 7
LISINOPRIL 822 642 6 3
NEXIUM 624 407 7 19
ZOLPIDEM TARTRATE 602 414 8 17
AMLODIPINE BESYLATE 567 454 9 5
TRAMADOL HCL 510 376 10 16
CRESTOR 503 391 11 20
GABAPENTIN 446 314 12 13
MELOXICAM 445 363 13 31
BYSTOLIC 414 332 14 99
CLOPIDOGREL 400 352 15 30
METOPROLOL TARTRATE 386 321 16 10
CYMBALTA 385 280 17 44
LOSARTAN POTASSIUM 365 283 18 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 363 268 19 28
LOSARTAN-HYDROCHLOROTHIAZIDE 362 290 20 46
ALLOPURINOL 338 247 21 37
SINGULAIR 313 245 22 85
PANTOPRAZOLE SODIUM 300 228 23 33
LOVAZA 298 162 24 97
TAMSULOSIN HCL 292 240 25 29
HYDROCHLOROTHIAZIDE 290 265 26 15
PLAVIX 283 238 27 40
ATORVASTATIN CALCIUM 281 208 28 9
FUROSEMIDE 276 215 29 6
TRICOR 258 178 30 91
GLIMEPIRIDE 253 213 31 36
MIRTAZAPINE 251 200 32 54
GLIPIZIDE 250 198 33 50
DIOVAN HCT 239 188 34 61
JANUVIA 234 176 35 48
NAMENDA 227 200 36 34
AZITHROMYCIN 211 149 37 38
SERTRALINE HCL 205 142 38 27
VOLTAREN 204 153 39 157
METOPROLOL SUCCINATE 202 186 40 11
IBUPROFEN 198 121 41 87
DEXILANT 197 178 42 186
BENICAR HCT 195 170 43 181
DONEPEZIL HCL 194 178 44 26
ESCITALOPRAM OXALATE 192 148 45 62
SPIRONOLACTONE 192 149 45 70
MONTELUKAST SODIUM 189 131 47 153
CARVEDILOL 182 160 48 21
ALENDRONATE SODIUM 177 153 49 23
WELCHOL 176 124 50 250
CELEBREX 176 146 50 89
VESICARE 174 117 52 154
GLYBURIDE-METFORMIN HCL 170 138 R 53 64
LANTUS 168 139 54 45
LEVEMIR FLEXPEN 165 110 55 156
LIDODERM 165 107 55 105
AMITIZA 163 123 57 296
LANTUS SOLOSTAR 162 71 58 92
WARFARIN SODIUM 159 105 59 22
ABILIFY 157 58 60 172
AVODART 156 121 61 151
EXELON 151 150 62 106
TOPIRAMATE 146 43 63 206
PRAVASTATIN SODIUM 142 115 64 12
NAPROXEN 140 103 65 80
ACTOPLUS MET 140 122 65 349
ACTOS 139 100 67 108
VENLAFAXINE HCL ER 135 91 68 120
CILOSTAZOL 131 116 69 165
POTASSIUM CHLORIDE 129 115 70 14
NITROFURANTOIN MONO-MACRO 128 96 71 162
PEN NEEDLE 124 63 72 110
AMLODIPINE BESYLATE-BENAZEPRIL 124 98 72 67
AMOX TR-POTASSIUM CLAVULANATE 122 80 74 112
JANUMET 116 100 75 131
ONGLYZA 116 98 75 210
PREDNISONE 114 93 77 42
RANEXA 113 107 78 440
MECLIZINE HCL 112 86 79 122
DIOVAN 111 100 80 35
LYRICA 111 69 80 69
POLYETHYLENE GLYCOL 3350 105 76 82 93
ATENOLOL 105 81 82 25
FAMOTIDINE 104 93 84 75
PRAMIPEXOLE DIHYDROCHLORIDE 104 89 84 202
DOXEPIN HCL 98 76 86 248
QUETIAPINE FUMARATE 97 62 87 66
SUCRALFATE 97 73 87 187
SEROQUEL XR 94 52 89 271
LOVASTATIN 87 76 90 41
TIZANIDINE HCL 86 31 91 133
CIPROFLOXACIN HCL 83 65 92 47
HYDRALAZINE HCL 78 70 93 59
ATELVIA 77 57 94 201
FINASTERIDE 76 67 95 102
LEVETIRACETAM 74 20 96 103
PAROXETINE HCL 73 38 97 84
FLUOXETINE HCL 72 33 98 83
BENICAR 72 66 98 138
PRISTIQ ER 70 52 100 343
BENAZEPRIL HCL 70 55 100 77
SEROQUEL 70 49 100 143
LEVOFLOXACIN 69 59 103 57
CITALOPRAM HBR 68 61 104 24
DOXAZOSIN MESYLATE 66 58 105 94
LIPITOR 66 37 105 78
LEVEMIR 66 52 105 135
NOVOFINE 66 44 105 532
BYETTA 64 19 109 322
CLOTRIMAZOLE-BETAMETHASONE 64 41 109 136
VALSARTAN-HYDROCHLOROTHIAZIDE 63 53 111 368
DETROL LA 63 51 111 192
DIGOXIN 63 30 111 55
PHENYTOIN SODIUM EXTENDED 62 42 114 128
GEMFIBROZIL 62 59 114 98
ADVAIR DISKUS 58 22 116 60
INSULIN SYRINGE 56 42 117 86
GLYBURIDE 56 43 R 117 58
NASONEX 56 42 117 168
PIOGLITAZONE HCL 53 33 R 120 248
DICYCLOMINE HCL 52 38 121 224
GLIPIZIDE ER 52 45 121 107
LEXAPRO 50 42 123 198
TRILIPIX 50 39 123 160
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 3, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.